The Meda Pharmaceutical product portfolio is focused primarily on respiratory, allergy, central nervous system, gastroenterology, musculoskeletal, rheumatology, erectile dysfunction, and women’s health products.
The product information presented here is intended for use in the United States only. Other countries may have different regulatory requirements and review practices that may require referencing different information.
To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc.
at 1-800-526-3840 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
| Product Name
(active ingredient) |
Prescribing Information | Product Web Site |
| Anadrol-50® Tablet, 50 mg (oxymetholone) |
Anadrol-50 Tablet Prescribing Information | |
| Astelin® Nasal Spray, 137 mcg (azelastine hydrochloride) |
Astelin Prescribing Information | www.astelin.com |
| Astepro® Nasal Spray, 0.15% (azelastine hydrochloride) |
Astepro Prescribing Information | www.astepro.com |
| BiferaRx® Tablet (iron supplement) |
BiferaRx Tablet Prescribing Information | www.biferarx.com |
| Butisol Sodium® Tablets, 30 mg and 50 mg
and Oral Solution, 30 mg/5 mL (butabarbital sodium) |
Butisol Sodium Tablet and Oral Solution Prescribing Information | |
| Calafol® Tablets (folic acid USP) |
Calafol Tablet Prescribing Information | |
| Cesamet® Capsules (nabilone) |
Cesamet Prescribing Information – 50 Count Bottle | www.cesamet.com |
| Colyte® Powder for Solution with Flavor Packets (peg-3350 & electrolytes) |
Colyte 4 Liter Prescribing Information | |
| Cortifoam® 10% Rectal Foam (hydrocortisone acetate rectal aerosol) |
Cortifoam Foam Prescribing Information | |
| Demadex® Tablets 5 mg, 10 mg, 20 mg, and 100 mg (torsemide) |
Demadex Tablet Prescribing Information | |
| Depen® (Penicillamine Tablets, USP) Titratable Tablets (penicillamine) |
Depen Tablet Prescribing Information | |
| Dipentum® Capsules (olsalazine sodium) |
Dipentum Capsule Prescribing Information | |
| COMING SOON DYMISTATM (azelastine hydrochloride and fluticasone propionate) Nasal Spray 137 mcg / 50 mcg per Spray |
Dymista Prescribing Information | www.dymista.com |
| Edluar® Sublingual Tablets, 5 mg and 10 mg (zolpidem tartrate) |
Edluar Sublingual Tablet Prescribing Information | www.edluar.com |
| Epifoam® Topical Aerosol (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) |
Epifoam Prescribing Information | |
| Felbatol® Tablets, 400 mg and 600 mg,
and Oral Suspension, 600 mg/5 mL (felbamate) |
Felbatol Tablet and Oral Suspension Prescribing Information | www.felbatol.com |
| Folpace® Tablets (folic acid USP) |
Folpace Tablet Prescribing Information | |
| Levbid® Extended-Release Tablet, 0.375mg (hyoscyamine sulfate) |
Levbid Tablet Prescribing Information | |
| Levsin®/SL Tablets (hyoscyamine sulfate tablets USP) |
Levsin/SL Tablet Prescribing Information | |
| Levsin® Injection (hyoscyamine sulfate injection USP) |
Levsin Injection Prescribing Information | |
| Levsin® Tablets (hyoscyamine sulfate tablets USP) |
Levsin Tablet Prescribing Information | |
| Lufyllin® Tablets, 200 mg and 400 mg (dyphylline) |
Lufyllin Tablet Prescribing Information | |
| Muse® Urethral Suppository
(alprostadil) |
MUSE Urethral Suppository Prescribing Information | www.muserx.net |
| NuLev®Chewable Melt Tablets (hyoscyamine sulfate USP) |
NuLev Tablet Prescribing Information | |
| Onsolis®
(fentanyl buccal soluble film) (fentanyl citrate) |
Onsolis Prescribing Information | www.onsolis.com |
| Optivar® 0.05% Ophthalmic Solution (azelastine hydrochloride) |
Optivar Prescribing Information | www.optivar.com |
| PreferaOB ONE® Softgel (Prenatal/Postnatal/Multivitamin/Multimineral/DHA) |
PreferaOB ONE Prescribing Information | www.preferaob.com |
| PreferaOB Tablet + DHA® Softgel (Prenatal/Postnatal/Multivitamin/Multimineral/DHA) |
PreferaOB + DHA Prescribing Information | www.preferaob.com |
| PreferaOB® Tablet (Prenatal/Postnatal/Multivitamin/Multimineral) |
PreferaOB Prescribing Information | www.preferaob.com |
| Proctofoam® (Non-Steriod) Hemorrhoidal Foam (pramoxine hydrochloride 1%) |
Proctofoam NS Prescribing Information | |
| Proctofoam® HC Aerosol Foam (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) |
Proctofoam HC Prescribing Information | |
| Rowasa® Rectal Suspension (mesalamine) |
Rowasa Prescribing Information | |
| sfRowasaTM Rectal Suspension, Sulfite-Free Formulation (mesalamine) |
sfRowasa Prescribing Information | |
| Soma® Tablets, 250 mg and 350 mg (carisoprodol) |
Soma Tablet Prescribing Information
|
www.soma250.com |
| TriLyte® Powder for Solution with Flavor Packs (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride) |
TriLyte Prescribing Information |
To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc.
at 1-800-526-3840 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.